N-{[1,6-Diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrozolo[3,4-b]pyridin-5-yl]methyl}-4-({8-[(2-hydroxyethyl) (methyl)amino]octanoyl}amino)benzamide ;pharmaceutical composition comprising said compound

Abstract

The invention provides a compound of NH formula (I): wherein Ar has the sub-formula (x): and wherein: Q1 is NH or NMe, in which case Q2 is -C(O)-, -S(0)2-, -C(0)NH- or -C(0)NMe-; or Q1 is a bond or -0-, in which case Q2 is a bond; or Q1 is -C(0)-, in which case Q2 is NH or NMe; or Q1 is -S(0)2-, in which case Q2 is NH, NMe or a bond; and L is (CH2)n wherein n is 4 to 13; or L is -(CH2)m1 -0-(CH2)m2 -. and pharmaceutical composition comprising the compound for use in the treatment and / or prophylaxis of an inflammatory and / or allergic disease.